Vertex Pharmaceuticals Incorporated vs Xcel Energy Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.47 (market cap $121.95B), while Xcel Energy Inc trades at $79 (market cap $49.11B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 2.5× Xcel Energy Inc's market cap, and Xcel Energy Inc pays a 3.01% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | XEL | |
|---|---|---|
Market Cap | $121.95B | $49.11B |
Sector | Health | Utilities |
52-Week High | $529.59 | $83.91 |
52-Week Low | $366.54 | $71.14 |
Enterprise Value | $116.69B | $86.55B |
Dividend Yield | — | 3.01% |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →